CAH

CAH

USD

Cardinal Health Inc. Common Stock

$149.530+2.250 (1.528%)

Real-time Price

Healthcare
Medical Distribution
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$147.280

High

$150.120

Low

$146.350

Volume

0.41M

Company Fundamentals

Market Cap

36.1B

Industry

Medical Distribution

Country

United States

Trading Stats

Avg Volume

2.59M

Exchange

NYQ

Currency

USD

52-Week Range

Low $93.17Current $149.530High $150.12

AI Analysis Report

Last updated: Apr 30, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

CAH: Cardinal Health Inc. Common Stock - Checking the Pulse on Recent Moves

Stock Symbol: CAH Generate Date: 2025-04-30 23:07:31

Alright, let's take a look at what's been happening with Cardinal Health lately and what the signals might be telling us. Think of this as breaking down the key points without getting lost in complicated finance talk.

Recent News Buzz: Analysts Like What They See

The news flow for CAH has been pretty positive on the analyst front. We saw two separate reports from big names – UBS and B of A Securities. Both firms already had a "Buy" rating on the stock, which is a good sign because it means they thought it was worth owning even before these latest updates.

What's notable is that both analysts decided to raise their price targets. UBS bumped theirs from $150 to $160, and B of A went from $150 to $155. Raising a price target usually suggests the analyst believes the company's future prospects or current value are better than they previously thought. So, the general vibe from these experts is definitely leaning optimistic right now.

Price Check: Climbing Towards the Top

Now, let's check out what the stock price itself has been doing. Looking back over the last couple of months, CAH had a bit of a dip in early April after a nice run-up in March. But since that dip, the price has been steadily climbing back up.

In fact, the stock closed today around $141.29. That's really close to its 52-week high of $141.73. Reaching a 52-week high is often seen as a sign of strength, showing the stock is trading at its highest point in a year. Volume was also a bit higher than average today, which can sometimes indicate increased interest. The recent trend is clearly upward, recovering well from that early April wobble.

Putting It Together: What Might Be Next?

So, we've got positive analyst sentiment with raised price targets, and the stock price has been moving up, hitting levels near its yearly high. The AI prediction also points to small positive movements over the next couple of days (+1.79% tomorrow, +0.21% the day after), suggesting the upward momentum might continue short-term.

Based on this, the near-term picture seems to favor the bulls – meaning there's a positive leaning right now.

What could this mean for potential action?

  • Potential Entry Consideration: The stock is currently trading right around $141.29, very close to its 52-week high. Buying right at a high can be risky, as prices sometimes pull back after hitting such levels. The AI's suggested entry points were slightly lower, around $139.80 to $140.32. If you were considering getting in, one approach might be to see if the stock pulls back slightly towards that $140 area, which could offer a slightly better entry point than buying right at the peak. However, if the strong momentum continues, it might just keep going. It's a bit of a balancing act here.
  • Potential Exit/Stop-Loss Consideration: If you're already in, or if you decide to enter, thinking about where you might take profits or limit losses is smart. The AI suggests a potential take-profit level around $142.65, which isn't far above the current price and the 52-week high. For managing risk, a potential stop-loss level suggested is $125.87. This level is quite a bit below the current price, offering a wide buffer, but it's a point where you might decide to exit if the price unexpectedly drops significantly.

Company Context: Healthcare Backbone

Remember, Cardinal Health is a major player in healthcare distribution. They're essentially a crucial link in getting medical supplies and pharmaceuticals to hospitals and pharmacies. This means their business is tied to the overall healthcare system's activity. Analyst views and price movements often reflect expectations about how well this core business is performing and will perform. The recent positive analyst notes suggest confidence in their role and execution within this sector.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Related News

Analyst Upgrades

UBS Maintains Buy on Cardinal Health, Raises Price Target to $170

UBS analyst Kevin Caliendo maintains Cardinal Health with a Buy and raises the price target from $160 to $170.

View more
UBS Maintains Buy on Cardinal Health, Raises Price Target to $170
Analyst Upgrades

Baird Maintains Outperform on Cardinal Health, Raises Price Target to $170

Baird analyst Eric Coldwell maintains Cardinal Health with a Outperform and raises the price target from $156 to $170.

View more
Baird Maintains Outperform on Cardinal Health, Raises Price Target to $170
PR Newswire

Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook

Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2025 revenues of $54.9 billion, flat to the third quarter of fiscal year 2024....

View more
Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook
Analyst Upgrades

UBS Maintains Buy on Cardinal Health, Raises Price Target to $160

UBS analyst Kevin Caliendo maintains Cardinal Health with a Buy and raises the price target from $150 to $160.

View more
UBS Maintains Buy on Cardinal Health, Raises Price Target to $160

AI PredictionBeta

AI Recommendation

Bullish

Updated at: May 2, 2025, 10:34 PM

BearishNeutralBullish

67.5% Confidence

Risk & Trading

Risk Level1/5
Low Risk
Suitable For
Conservative
Trading Guide

Entry Point

$145.23

Take Profit

$148.49

Stop Loss

$131.02

Key Factors

PDI 5.3 is above MDI 4.8 with ADX 12.7, suggesting bullish trend
Current Price is extremely close to support level ($145.42), suggesting strong buying opportunity
Trading volume is 16.4x average (24,234), indicating extremely strong buying pressure
MACD 0.1177 is above signal line 0.1127, indicating a bullish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.